TEVA PHARMACEUTICALS INTERNATIONAL GMBH Trademark Portfolio
TEVA PHARMACEUTICALS INTERNATIONAL GMBH owns 27 live USPTO trademarks across 7 Nice classes. Earliest filing: 2003-06-11; most recent: 2025-09-08.
Portfolio Overview
| Total Marks | 100 |
|---|---|
| Live Marks | 27 |
| Registered | 10 |
| Pending | 17 |
| Earliest Filing | 2003-06-11 |
| Latest Filing | 2025-09-08 |
Top Classes
Class 005 (Pharmaceuticals), Class 037 (Construction), Class 035 (Advertising & Business), Class 044 (Medical Services), Class 016 (Paper Goods), Class 041 (Education & Entertainment), Class 042 (Software & IT)
Recently Registered Marks
- AJOVY — registered 2019-01-01
- Trademark 87879887 — registered 2019-01-01
- AJOVY — registered 2018-12-18
- SYNCARE — registered 2017-07-18
- SYNCARE — registered 2017-07-18
Recently Filed Applications
Top Marks
- LESS MIGRAINE. MORE MOMENTS. — Cancelled
- LESS MIGRAINE, MORE MOMENTS — Cancelled
- AJOVY — Registered
- Trademark 87879887 — Registered
- AJOVY — Registered
- SYNCARE — Cancelled
- SYNCARE — Cancelled
- SYNCARE — Cancelled
- SYNCARE — Registered
- SYNCARE — Registered
- SYNCARE — Cancelled
- BENDEKA (BENDAMUSTINE HCI) INJECTION — Registered
- BENDEKA (BENDAMUSTINE HCI) INJECTION — Registered
- BENDEKA — Registered
- Trademark 85410884 — Cancelled
- ZECUITY — Cancelled
- ZECUITY — Cancelled
- SYNRIBO — Cancelled
- ZENTRUDO — Cancelled
- HUNTEXIL — Cancelled
- NUVIGIL — Cancelled
- Trademark 77659612 — Cancelled
- AMRIX — Registered
- QOELLE — Cancelled
- MENAELLE — Cancelled
- AMRIX — Registered
- STEZZA — Cancelled
- ZELTIEN — Cancelled
- STAMIAR — Cancelled
- GLIRIZ — Cancelled
- IOA — Cancelled
- CHISPREL — Cancelled
- LUCIAD — Cancelled
- DEZUAN — Cancelled
- CHYNDRA — Cancelled
- NADZAE — Cancelled
- ONASEVE — Cancelled
- DESUANCE — Cancelled
- POJEZ — Cancelled
- NACREZ — Cancelled
- NUPATHE — Cancelled
- VEDUSI — Abandoned
- VEDUVI — Abandoned
- KALTYVI — Abandoned
- KELMEVDI — Abandoned
- AMLIRI — Abandoned
- TYVEZMI — Abandoned
- CRELVODI — Abandoned
- RELMABI — Abandoned
- ENLIBI — Pending